Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
A 6-week clinical trial in patients with metabolic syndrome and hypercholesterolemia at high
risk for coronary heart disease to study the effects of ezetimibe/simvastatin and
atorvastatin on lipids.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Atorvastatin Atorvastatin Calcium Calcium Ezetimibe Ezetimibe, Simvastatin Drug Combination Simvastatin